For the past 15 years or so, a class of drugs called immune checkpoint inhibitors have been used to treat melanoma – the most ...

Emerging growth opportunities in the next-generation immune checkpoint inhibitors market include the development of therapies targeting novel immune pathways employed to tackle cancer resistance ...

New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...

Please provide your email address to receive an email when new articles are posted on . Education about immune-related adverse events associated with checkpoint inhibitor therapy for cancer is ...

Immunotherapies such as so-called checkpoint inhibitors activate the body's own immune system to fight cancer cells and have ...

Researchers found that lowering MHC I can expose cancerous or foreign cells to CD4+ T cell attack, reshaping assumptions ...

In 2012, neuroscientist Gary Landreth and his team at Case Western Reserve University published a finding in Science that ...

Comparison of adverse effect profile of PD-1 and CTLA-4 inhibitors and its variation with race and BMI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

Objective Immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment and patients’ survival. However, ICIs also ...

The medications most likely to cause thyroid eye disease are alemtuzumab, certain immune checkpoint inhibitors, amiodarone ...